Elanco Animal Health Faces Class Action Lawsuit

A class action securities lawsuit has been filed against Elanco Animal Health Incorporated alleging that the company misled investors about the safety and approval timelines of its products, Zenrelia and Credelio Quattro. The lawsuit claims that Elanco's statements were materially false and concealed crucial safety concerns about Zenrelia, contributing to overstatements of the company's financial prospects. Following a June 2024 announcement that FDA approval for Zenrelia would include a boxed warning, Elanco's stock plummeted by over 21%. Investors affected by this alleged securities fraud have until December 6, 2024, to seek lead plaintiff status in the case. Law firms such as Levi & Korsinsky and Faruqi & Faruqi are actively encouraging impacted shareholders to participate in the lawsuit. Those interested can obtain further information on their respective sites.